Related Experiment Video
Updated: Feb 28, 2026
10:58
Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma
Published on: February 22, 2015
13.5K
Cervical spinal glioblastoma multiforme in the elderly
Dmitri Shastin1, Ryan K Mathew2, Azzam Ismail3
1Department of Neurosurgery, Cardiff University, University Hospital of Wales, Cardiff, UK.
BMJ Case Reports
|June 15, 2017
Summary
Spinal glioblastoma multiforme (GBM) is rare and challenging to diagnose, particularly in older adults. This report discusses management and treatment options for elderly patients with this condition.
Area of Science:
- Neuro-oncology
- Geriatric Medicine
- Spinal Cord Pathology
Background:
- Spinal glioblastoma multiforme (GBM) is an uncommon and challenging diagnosis, especially in the elderly.
- Optimal management strategies for spinal GBM in older adults are not well-defined.
- This report aims to document this rare condition and increase awareness.
Observation:
- Diagnosis of spinal GBM can be particularly difficult in the elderly population.
- Cervical spinal GBM may have a better prognosis than intramedullary metastasis.
- Biopsy can be beneficial in specific circumstances for spinal GBM.
Findings:
- Spinal GBM is a rare entity with diagnostic challenges, especially in elderly patients.
- The literature review suggests potential treatment options for this demographic.
- Prognosis may vary, with cervical spinal GBM potentially faring better than intramedullary metastasis.
Implications:
- Increased awareness of spinal GBM as a differential diagnosis in the elderly is crucial.
- Further research is needed to define the best management strategies for spinal GBM in older adults.
- Timely diagnosis and appropriate treatment, potentially including biopsy, can impact patient outcomes.
Related Concept Videos
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
285
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
285
01:15Drug Dosing: Geriatric Patients
328
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
328